Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Market update

25 Sep 2014 07:27

RNS Number : 5777S
Tungsten Corporation PLC
25 September 2014
 

TUNGSTEN CORPORATION PLC 

 

("Tungsten" or the "Company")

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN NOR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

For Immediate Release 25 September 2014

 

 

Market update

Pharmaceutical and healthcare companies continue to choose Tungsten Network

Seven of the top-twelve global pharmaceutical businesses use the global e-Invoicing network

 

London, 25 September - Tungsten Network is the e-Invoicing provider of choice for the world's leading pharmaceutical and healthcare companies.

The latest organisations to select Tungsten Network include Fresenius Medical Care NA, a US-based provider of kidney dialysis services and renal care products, and Dana-Farber Cancer Institute, a world leader in cancer treatment and research.

These new customers join the global e-Invoicing network alongside long-term practitioners, such as GlaxoSmithKline, and reinforce Tungsten's strength in this industry. Seven of the twelve largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.

"The pharmaceutical sector has been an early adopter of e-Invoicing with our first customer from the industry joining the network in 2004," says Edmund Truell, Tungsten Group CEO. "It's befitting that an industry focused on innovation is equally pioneering in its own business practices."

 

Enquiries:

 

Tungsten Corporation plc

Edmund Truell, Chief Executive Officer +44 20 3435 5680

 

Charles Stanley Securities

(Nominated Adviser and Joint Broker)

Marc Milmo/Dugald Carlean +44 20 7149 6000

 

Canaccord Genuity Limited

(Joint Broker)

Simon Bridges/Peter Stewart/Cameron Duncan +44 20 7523 8000

 

Equus Group (Communications)

Piers Hooper / Sam Barton +44 20 7223 1100

 

About Tungsten Corporation plcTungsten Corporation (LSE: TUNG) accelerates global trade by enabling customers to streamline invoice processing, improve cash-flow management and make better buying decisions from their detailed spend data.

 

Buyer organisations that join Tungsten Network, built on OB10 e-Invoicing, can reduce their invoice-processing costs by 60%. Suppliers benefit from efficiencies, greater visibility of their invoice status and peace of mind. Tungsten offers supply chain financing through Tungsten Bank and helps buying organisations profit by applying real-time spend analytics to its vast repository of line-level invoice data.

 

Tungsten serves 53% of the Fortune 500 and 66% of the FTSE 100 by connecting the world's largest companies and government agencies to their thousands of suppliers around the globe. It is compliant in 46 countries, and last year processed transactions worth over $187bn for organisations such as Alliance Data, Aviva, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg's, and US Federal Government.

 

Tungsten Corporation joined forces with OB10 in 2013 to create the world's largest electronic trading network.

 

Contact: Sandra Higgison, Head of Global Communications, +44 20 7280 7973, sandra.higgison@tungsten-network.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALAMFTMBBTMLI
Date   Source Headline
31st Jul 20181:54 pmRNSHolding(s) in Company
27th Jul 20181:14 pmRNSGrant of Share Options
24th Jul 20185:48 pmRNSAnnual Report & Accounts Uploaded to Website
23rd Jul 20187:00 amRNSFinal Results for the year ended 30 April 2018
20th Jul 20183:22 pmRNSRequisition Update & Proposed Board Appointments
10th Jul 20189:00 amRNSLaunch of billing service for Accounts Receivable
4th Jul 20185:25 pmRNSExercise of Options / Additional Listing
29th Jun 20184:32 pmRNSNotice of Requisition of General Meeting
27th Jun 201810:25 amRNSTungsten Network > £300m financing since relaunch
14th Jun 20187:00 amRNSComment on press speculation
6th Jun 20182:14 pmRNSHolding(s) in Company
4th Jun 20187:00 amRNSTrading Update
21st May 20183:54 pmRNSNotice of Pre-Close Trading Update & FY18 Results
8th May 20187:00 amRNSHolding(s) in Company - Indus Capital
20th Apr 20187:47 amRNSHolding(s) in Company - DCIL
5th Feb 20187:00 amRNSHolding(s) in Company
8th Jan 20187:00 amRNSTungsten Network Finance accelerates growth
14th Dec 20177:00 amRNSInterim Results for six months to 31 October 2017
1st Dec 20179:00 amRNSNotice of Interim Results
4th Oct 20172:19 pmRNSHolding(s) in Company
15th Sep 20174:53 pmRNSResult of AGM
15th Sep 20177:00 amRNSAGM Statement & Trading Update
7th Sep 201710:18 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSMailing of Annual Report and Notice of AGM
11th Aug 201712:07 pmRNSSecond Price Monitoring Extn
11th Aug 201712:02 pmRNSPrice Monitoring Extension
4th Aug 20178:01 amRNSDirector/PDMR Shareholding-Grant of Share Options
24th Jul 20177:00 amRNSFinancial Report for 12 months ended 30 April 2017
13th Jun 201712:07 pmRNSSecond Price Monitoring Extn
13th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20177:01 amRNSDirectorate Change
24th May 20177:00 amRNSPre-close FY17 Trading Update
17th May 20171:15 pmRNSNotice of Pre-Close Trading Update & FY17 Results
15th May 201712:07 pmRNSSecond Price Monitoring Extn
15th May 201712:02 pmRNSPrice Monitoring Extension
3rd May 20177:00 amRNSDirector/PDMR Shareholding - Nick Parker
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
30th Jan 20177:07 amRNSDirector/PDMR Shareholding
10th Jan 201710:41 amRNSHolding(s) in Company
22nd Dec 20167:00 amRNSCompletion of Bank Sale
21st Dec 201612:55 pmRNSHolding(s) in Company
20th Dec 20169:35 amRNSDirector/PDMR Shareholding
14th Dec 20167:00 amRNSHalf-year Report
16th Nov 20167:00 amRNSSale of Tungsten Bank Receives Regulatory Approval
1st Nov 20167:00 amRNSUpdate on Sale of Tungsten Bank
19th Oct 20162:22 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSDirector/PDMR Shareholding
13th Oct 20169:37 amRNSSettlement of Tax
21st Sep 20166:11 pmRNSDirector/PDMR Shareholding - David Benello

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.